DEF 14A: Nocopi Technologies Seeks Stockholder Approval for 2024 Incentive Compensation Plan and Auditor Ratification

Nocopi Technologies is holding its annual meeting on June 17, 2024, to vote on proposals including the approval of a new incentive compensation plan, ratification of its independent auditor, and an advisory vote on executive compensation.

Summary

• Nocopi Technologies, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 17, 2024.
• Stockholders will vote on three proposals: approving the 2024 Incentive Compensation Plan, ratifying the appointment of Morison Cogen, LLP as the independent auditor for the year ending December 31, 2024, and approving, on an advisory basis, the compensation of named executive officers.
• The Board of Directors recommends voting FOR all three proposals.
• The record date for determining stockholders eligible to vote is April 15, 2024.
• The company had 10,501,178 shares of common stock outstanding as of the record date.
• The 2024 Incentive Compensation Plan reserves 2,000,000 shares for awards, with an automatic annual increase of up to 5% of outstanding shares, commencing on January 1, 2025 and ending on January 1, 2034.
• The maximum value of awards to any non-employee director in a fiscal year is capped at $250,000.
• Michael S. Liebowitz, the CEO, received a one-time equity award of 1,000,000 restricted stock units valued at $3,580,000, vesting on August 18, 2024.
• As of the record date, directors and executive officers as a group beneficially owned 3,154,350 shares, representing approximately 30.0% of the company's common stock.

Sentiment

Score: 6

Explanation: The document is neutral in tone, primarily providing factual information about the upcoming annual meeting and proposals. The Board's recommendations are clearly stated, but there is no overt promotion or downplaying of any issues.

Positives

• The 2024 Incentive Compensation Plan is designed to attract, motivate, retain, and reward high-quality executives and other employees, officers, directors, and individual consultants.
• The company is committed to good corporate governance practices by holding an annual meeting and seeking stockholder input on key decisions.
• The Board of Directors is actively involved in overseeing the management of the company's risks.
• The company has a Code of Ethics in place that applies to its Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and persons performing similar functions.

Negatives

• The company's common stock is traded on the OTC Pink tier of the over-the-counter (OTC) market, which may indicate higher risk and lower liquidity compared to exchanges with stricter listing requirements.
• The company does not have a separately designated nominating or compensation committee, with the full Board serving in these capacities, which may raise concerns about independence and expertise in these areas.
• The company does not currently have a policy prohibiting employees, officers, or directors from engaging in transactions that hedge or offset any decrease in the market value of the company's equity securities.

Risks

• The company's reliance on key personnel, particularly executive officers, poses a risk if these individuals were to leave or become unable to perform their duties.
• The company's smaller size and limited resources may make it more vulnerable to economic downturns and competitive pressures.
• The company's stock price may be volatile due to its trading on the OTC Pink market and other factors.
• The company's success depends on its ability to effectively manage risks related to credit, liquidity, operations, cybersecurity, and potential conflicts of interest.

Future Outlook

The company intends to evaluate individuals in the future to consider additional members for the Board following the 2024 Annual Meeting, and any such additional Directors would be designated as Class III Directors.

Management Comments

• The Board believes that a favorable vote for all the Proposals described in the Proxy Statement is in the best interest of the Company and its stockholders and recommends a vote FOR for Proposals 1, 2 and 3.
• The Board has determined that presently, this leadership structure is appropriate for the size of our Company.

Industry Context

As a small company traded on the OTC Pink market, Nocopi Technologies' corporate governance practices and executive compensation are likely to be scrutinized by investors and regulatory bodies. The adoption of an incentive compensation plan and the ratification of an independent auditor are standard practices for publicly traded companies.

Comparison to Industry Standards

• The structure of Nocopi's board, with a combined CEO and Chairman role, is less common among larger, exchange-listed companies, where separation of these roles is often seen as a best practice for corporate governance.
• The level of executive compensation, particularly the stock award to the CEO, should be assessed in relation to the company's size, performance, and industry peers.
• The absence of a dedicated nominating or compensation committee is atypical for publicly traded companies and may raise concerns about the independence of these functions.
• Comparable companies in the specialty chemicals or security technology sectors, such as Nano-X Imaging Ltd. or Identiv, Inc., may serve as benchmarks for evaluating Nocopi's corporate governance and compensation practices.

Related Party Transactions

• On September 13, 2022, our Company issued 1,250,000 shares of our common stock to MSL 18 HOLDINGS LLC. in exchange for $1,750,000 ($1.40 per share) pursuant to a stock purchase agreement.
• On September 11, 2023, the Company engaged Phillip Frost, the trustee of Frost Gamma Investments Trust, a beneficial owner of greater than 5% of our outstanding voting securities, as a consultant to provide general advisory services to the Company for a three-year period ending on September 11, 2026.

Stakeholder Impact

• Approval of the 2024 Incentive Compensation Plan could impact shareholders by aligning executive compensation with company performance and potentially increasing shareholder value.
• Ratification of the independent auditor is important for maintaining investor confidence in the company's financial statements.
• The advisory vote on executive compensation allows shareholders to express their views on the company's pay practices.

Next Steps

• Stockholders are urged to review the proxy materials carefully and vote promptly.
• The company will report the final voting results within four business days of the 2024 Annual Meeting on a Current Report on Form 8-K.
• The Board may evaluate individuals in the future to consider additional members for our Board following the 2024 Annual Meeting.

Key Dates

Keywords

proxy statement, annual meeting, incentive compensation, executive compensation, stockholders, corporate governance, Morison Cogen, auditor ratification, Nocopi Technologies, NNUP